AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Haleon PLC

Director's Dealing Jul 20, 2022

5111_dirs_2022-07-20_1688e1b2-ac50-453e-aa25-99e57664138e.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 2025T

Haleon PLC

20 July 2022

HALEON PLC 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

20 July 2022 

Notification and Public Disclosure in accordance with the requirements of The EU Market Abuse Regulation of Transactions by Persons Discharging Managerial Responsibilities ("PDMR") and Persons Closely Associated with them. 

On 18 July 2022, Haleon plc (the "Company") received notification of the following transaction as detailed below. 

1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Brian McNamara
2 Reason for the notification
a) Position/status Chief Executive Officer - Person Discharging Managerial Responsibilities
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US405552100
b) Nature of the transaction ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c) Price(s) and volume(s)
Price(s) Volume(s)
n/a 121,929
d) Aggregated information
- Aggregated volume 121,929
- Price n/a
e) Date of the transaction 18 July 2022
f) Place of the transaction New York Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Amy Landucci
2 Reason for the notification
a) Position/status Chief Digital and Technology Officer - Person Discharging Managerial Responsibilities
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US405552100
b) Nature of the transaction ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c) Price(s) and volume(s)
Price(s) Volume(s)
n/a 5,681
d) Aggregated information
- Aggregated volume 5,681
- Price n/a
e) Date of the transaction 18 July 2022
f) Place of the transaction New York Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Teri Lyng
2 Reason for the notification
a) Position/status Head of Transformation and Sustainability - Person Discharging Managerial Responsibilities
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US405552100
b) Nature of the transaction ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c) Price(s) and volume(s)
Price(s) Volume(s)
n/a 19,049
d) Aggregated information
- Aggregated volume 19,049
- Price n/a
e) Date of the transaction 18 July 2022
f) Place of the transaction New York Stock Exchange
1 Details of the person discharging managerial responsibilities / person closely associated
a) Name Lisa Paley
2 Reason for the notification
a) Position/status President, North America - Person Discharging Managerial Responsibilities
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Haleon plc
b) LEI 549300PSB3WWEODCUP19
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument Haleon plc American Depositary Shares (ADS)
Identification code US405552100
b) Nature of the transaction ADSs received in the Company on 18 July 2022, in accordance with the terms of the demerger from GSK as disclosed in the Company's prospectus dated 1 June 2022.
c) Price(s) and volume(s)
Price(s) Volume(s)
n/a 7,126
d) Aggregated information
- Aggregated volume 7,126
- Price n/a
e) Date of the transaction 18 July 2022
f) Place of the transaction New York Stock Exchange

Amanda Mellor 

Company Secretary 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBLGDRIBDDGDG

Talk to a Data Expert

Have a question? We'll get back to you promptly.